title: Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome.
abstract: Subclinical acute rejection (SAR) occurs in about 30% of stable renal transplant patients and may be a risk factor for a poor allograft outcome. In the present study, the prevalence and clinical features of subclinical rejection, and the expression of immune activation markers in surveillance graft biopsies were assessed and correlated with late graft outcomes. Protocol biopsies were obtained at 2 and 12 months post-transplant in 32 and 26 patients, respectively, with stable renal function. The Banff 1997 criteria were used for histological diagnosis. Graft function and survival and proteinuria were assessed during the 36 months of follow-up. Immunohistochemical evaluation of cell subpopulations and immunoactivation markers were performed on protocol biopsies. The prevalence of SAR at 2 months and of chronic allograft nephropathy (CAN) at 12 months in representative biopsies was 55 and 50%, respectively. Patients with SAR presented mononuclear cell infiltration with an increased expression of CD3, CD4, CD68, IL-2R and granzyme B. Kidney graft function was significantly worse in patients with SAR at 2 months who had chronic rejection on biopsy at 12 months, but SAR was not associated with a worse graft function, greater proteinuria or a lower graft survival in 3 yr of follow-up. In conclusion, we found an elevated prevalence of SAR at 2 months after transplantation with an increased expression of activation markers. Although an association of SAR with poor graft outcome was not observed, our results suggest that SAR is an immunologically active process and underscore the importance of protocol biopsies in the surveillance of transplanted kidneys.
authors.affiliation: Renal Division and Post-Graduation Nephrology Program, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. franvero@via-rs.net
authors.forename: Francisco V
authors.initials: FV
authors.lastname: Veronese
authors.forename: Irene L
authors.initials: IL
authors.lastname: Noronha
authors.forename: Roberto C
authors.initials: RC
authors.lastname: Manfro
authors.forename: Maria I
authors.initials: MI
authors.lastname: Edelweiss
authors.forename: Julio
authors.initials: J
authors.lastname: Goldberg
authors.forename: Luiz F
authors.initials: LF
authors.lastname: Gonçalves
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D006085:Graft Survival / Q000276:immunology / Q000502:physiology; D006801:Humans; D007150:Immunohistochemistry; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011507:Proteinuria / Q000378:metabolism; D014184:Transplantation, Homologous
chemical_list: D015703:Antigens, CD; D003404:Creatinine